US FDA's Anesthesiology and Respiratory Therapy Devices Panel will consider a first-of-a-kind implantable lung reduction coil for emphysema on June 14.
The agency scheduled the panel to consider BTG PLC’s PMA for the PneumRx ELEVAIR endobronchial coil system. It's intended...